Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells

Analytical Biochemistry

Volumn 364, Issue 1, 2007, Pages 51-59

  Manceur, Aziza ^a,b   Wu, Alice ^a   Audet, Julie ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell penetrating peptides; Flow cytometry; Peptide transduction; Protein transduction domains; Stem cells

Indexed keywords

ARGININE; BACTERIOPHAGES; BONE; CELL CULTURE; DISEASES; FLOW CYTOMETRY; HYDROPHOBICITY; PEPTIDES;

CELL PENETRATING PEPTIDES (CPPS); CELL-PENETRATING PEPTIDE; EMBRYONIC STEM CELLS; FIBROBLAST GROWTH FACTOR; HEMATOPOIETIC CELL LINE; HYDROPHOBIC PEPTIDES; PEPTIDE TRANSDUCTION; PROTEIN TRANSDUCTION DOMAINS;

STEM CELLS;

ANTENNAPEDIA PROTEIN; ARGININE; ATAXIN 1; CELL PENETRATING PEPTIDE; DNA; FIBROBLAST GROWTH FACTOR; HEPATITIS B SURFACE ANTIGEN; KAPOSI SARCOMA FIBROBLAST GROWTH FACTOR; PROTEIN TRANSDUCTION DOMAIN 4; SYNTHETIC PEPTIDE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL TYPE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; INTERNALIZATION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

HEPATITIS B VIRUS;

EID: 33947688612     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.02.015     Document Type: Article

References (39)

1. Dominguez-Bendala J., Klein D., Ribeiro M., Ricordi C., Inverardi L., Pastori R., and Edlund H. TAT-mediated neurogenin 3 protein transduction stimulates pancreatic endocrine differentiation in vitro. Diabetes 54 (2005) 720-726
2. Sauvageau G., Iscove N.N., and Humphries R.K. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 23 (2004) 7223-7232
3. Dietz G.P., and Bahr M. Delivery of bioactive molecules into the cell: The Trojan horse approach. Mol. Cell. Neurosci. 27 (2004) 85-131
4. Kwon Y.D., Oh S.K., Kim H.S., Ku S.Y., Kim S.H., Choi Y.M., and Moon S.Y. Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction. Mol. Ther. 12 (2005) 28-32
5. N. Peitz, B. Munst, F. Edenhofer, Cell permeable recombinant TAT-Nanog fusion protein maintains self-renewal of ES cells, Stem Cells, Keystone Symposia Conference, Whistler, BC, Canada (2006) 97.
6. Prochiantz A. Messenger proteins: Homeoproteins, TAT, and others. Curr. Opin. Cell Biol. 12 (2000) 400-406
7. Frankel A.D., and Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55 (1988) 1189-1193
8. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
9. Prochiantz A., and Joliot A. Can transcription factors function as cell-cell signalling molecules?. Nat. Rev. Mol. Cell. Biol. 4 (2003) 814-819
10. Mi Z., Mai J., Lu X., and Robbins P.D. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2 (2000) 339-347
11. Oess S., and Hildt E. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther. 7 (2000) 750-758
12. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., and Hawiger J. Inhibition of nuclear translocation of transcription factor NF-(B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270 (1995) 14255-14258
13. Zigmond S.H., Sullivan S.J., and Lauffenburger D.A. Kinetic analysis of chemotactic peptide receptor modulation. J. Cell. Biol. 92 (1982) 34-43
14. Spooncer E., Heyworth C.M., Dunn A., and Dexter T.M. Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation 31 (1986) 111-118
15. Karasuyama H., and Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18 (1988) 97-104
16. Fok E.Y., and Zandstra P.W. Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells 23 (2005) 1333-1342
17. Thomas T.E., Miller C.L., and Eaves C.J. Purification of hematopoietic stem cells for further biological study. Methods 17 (1999) 202-218
18. Tropepe V., Sibilia M., Ciruna B.G., Rossant J., Wagner E.F., and van der Kooy D. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev. Biol. 208 (1999) 166-188
19. Letoha T., Gaal S., Somlai C., Venkei Z., Glavinas H., Kusz E., Duda E., Czajlik A., Petak F., and Penke B. Investigation of penetratin peptides: II. In vitro uptake of penetratin and two of its derivatives. J. Peptide Sci. 11 (2005) 805-811
20. Henriques S.T., Costa J., and Castanho M.A. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: A fluorescence study using Pep-1. FEBS Lett. 579 (2005) 4498-4502
21. Belting M. Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28 (2003) 145-151
22. Safaiyan F., Kolset S.O., Prydz K., Gottfridsson E., Lindahl U., and Salmivirta M. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J. Biol. Chem. 274 (1999) 36267-36273
23. Sahlin S., Hed J., and Rundquist I. Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. J. Immunol. Methods 60 (1983) 115-124
24. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides: A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
25. Maiolo J.R., Ferrer M., and Ottinger E.A. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim. Biophys. Acta 1712 (2005) 161-172
26. Dietz G.P., and Bahr M. Peptide-enhanced cellular internalization of proteins in neuroscience. Brain Res. Bull. 68 (2005) 103-114
27. Console S., Marty C., Garcia-Echeverria C., Schwendener R., and Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278 (2003) 35109-35114
28. Thoren P.E., Persson D., Isakson P., Goksor M., Onfelt A., and Norden B. Uptake of analogs of penetratin, Tat(48-60), and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307 (2003) 100-107
29. Jo D., Lin Q., Nashabi A., Mays D.J., Unutmaz D., Pietenpol J.A., and Ruley H.E. Cell cycle-dependent transduction of cell-permeant Cre recombinase proteins. J. Cell. Biochem. 89 (2003) 674-687
30. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 7 (1993) 1023-1030
31. Sandgren S., Cheng F., and Belting M. Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide: Role for cell-surface proteoglycans. J. Biol. Chem. 277 (2002) 38877-38883
32. Tyagi M., Rusnati M., Presta M., and Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276 (2001) 3254-3261
33. Stocker G., Drzeniek Z., Just U., Ostertag W., Siebertz B., Greiling H., and Haubeck H.D. Proteoglycan synthesis in human and murine haematopoietic progenitor cell lines: Isolation and characterization of a heparan sulphate proteoglycan as a major proteoglycan from the human haematopoietic cell line TF-1. Biochem. J. 317 (1996) 203-212
34. Schofield K.P., Gallagher J.T., and David G. Expression of proteoglycan core proteins in human bone marrow stroma. Biochem. J. 343 (1999) 663-668
35. Drzeniek Z., Stocker G., Siebertz B., Just U., Schroeder T., Ostertag W., and Haubeck H.D. Heparan sulfate proteoglycan expression is induced during early erythroid differentiation of multipotent hematopoietic stem cells. Blood 93 (1999) 2884-2897
36. Liuzzo J.P., and Moscatelli D. Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: Downmodulation of FGF receptors by phorbol ester. Blood 87 (1996) 245-255
37. Siebertz B., Stocker G., Drzeniek Z., Handt S., Just U., and Haubeck H.D. Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells. Biochem. J. 344 (1999) 937-943
38. Hung C.F., He L., Juang J., Lin T.J., Ling M., and Wu T.C. Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen. J. Virol. 76 (2002) 2676-2682
39. Green M., and Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 (1988) 1179-1188